Alyftrek Interactions
There are 245 drugs known to interact with Alyftrek (deutivacaftor/tezacaftor/vanzacaftor), along with 2 disease interactions, and 3 alcohol/food interactions. Of the total drug interactions, 86 are major, 157 are moderate, and 2 are minor.
- View all 245 medications that may interact with Alyftrek
- View Alyftrek alcohol/food interactions (3)
- View Alyftrek disease interactions (2)
Most frequently checked interactions
View interaction reports for Alyftrek (deutivacaftor / tezacaftor / vanzacaftor) and the medicines listed below.
- A/Fish Oil (vitamin a)
- Acid Reducer-Famotidine (famotidine)
- Acidophilus (lactobacillus acidophilus)
- Actemra (tocilizumab)
- Advair HFA (fluticasone / salmeterol)
- Andembry (garadacimab)
- AquADEKs (multivitamin with minerals)
- azithromycin
- Cayston (aztreonam)
- clindamycin
- Creon (pancrelipase)
- doxycycline
- Fiasp (insulin aspart)
- Humalog (insulin lispro)
- lansoprazole
- melatonin
- posaconazole
- prednisone
- Prozac (fluoxetine)
- Pulmozyme (dornase alfa)
- Singulair (montelukast)
- Symbicort (budesonide / formoterol)
- TOBI Podhaler (tobramycin)
- Tresiba (insulin degludec)
- Trikafta (elexacaftor / ivacaftor / tezacaftor)
- vancomycin
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Zoloft (sertraline)
- Zyrtec (cetirizine)
Alyftrek alcohol/food interactions
There are 3 alcohol/food interactions with Alyftrek (deutivacaftor / tezacaftor / vanzacaftor).
Alyftrek disease interactions
There are 2 disease interactions with Alyftrek (deutivacaftor / tezacaftor / vanzacaftor) which include:
Report options
More about Alyftrek (deutivacaftor / tezacaftor / vanzacaftor)
- Alyftrek consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: CFTR combinations
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
